Imatinib as Second-Line Therapy, Ameliorates or Maintains Molecular Responses Obtained with Ponatinib First-Line in Chronic Phase CML Patients

被引：0

作者：

Nicolini, Franck E. ^{[1
,2
]}

Fossard, Gaelle ^{[1
]}

Coiteux, Valerie ^{[2
,3
]}

Dubruille, Viviane ^{[2
,4
]}

Alcazer, Vincent ^{[1
]}

Sobh, Mohamad ^{[1
]}

Mouchel, Pierre ^{[5
]}

Mahon, Francois-Xavier ^{[2
,6
]}

Etienne, Gabriel ^{[2
,6
]}

Guerci, Agnes ^{[2
,7
]}

机构：

[1] Ctr Hosp Lyon Sud, Hematol Dept 1G, Pierre Benite, France

[2] Fi LMC Grp, Pessac, France

[3] CHU Lille, Hematol, Lille, France

[4] Hop Hotel Dieu, Dept Hematol, Nantes, France

[5] Incyte Biosci, Paris, France

[6] Inst Bergonie, Dept Hematol, Bordeaux, France

[7] CHU Brabois, Dept Hematol, Nancy, France

来源：

关键词：

D O I：

10.1182/blood.V128.22.1894.1894

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1894

引用

页数：5